V
Volkmar Falk
Researcher at Charité
Publications - 916
Citations - 97746
Volkmar Falk is an academic researcher from Charité. The author has contributed to research in topics: Medicine & Aortic valve. The author has an hindex of 93, co-authored 801 publications receiving 85653 citations. Previous affiliations of Volkmar Falk include University of Göttingen & Intuitive Surgical.
Papers
More filters
Journal ArticleDOI
Functional tricuspid valve insufficiency after cardiac transplantation: Which factor is the most important?
Vüsal Hajiyev,Michael Dandel,Ruhi Yeter,Felix Schoenrath,Felix Hennig,Volkmar Falk,Christoph Knosalla +6 more
TL;DR: Changes in tricuspid annulus geometry, number of biopsies, and dialysis are the most important risk factors for the development and progression of tric Suspid insufficiency following cardiac transplantation.
Journal ArticleDOI
Minimally invasive surgical aortic valve replacement through a right anterolateral thoracotomy.
Karel M Van Praet,Karel M Van Praet,Antonia van Kampen,Antonia van Kampen,Markus Kofler,Axel Unbehaun,Axel Unbehaun,Matthias Hommel,Stephan Jacobs,Volkmar Falk,Jörg Kempfert,Jörg Kempfert +11 more
TL;DR: The patient presented is a low-risk male with severe bicuspid aortic valve stenosis and the method of right anterolateral minithoracotomy uses femoral percutaneous cannulation, a high-definition thoracoscope and a transthoracic cross-clamp.
Journal ArticleDOI
Outcomes after Transcatheter Aortic Valve Implantation: a Single Center Registry of 350 Consecutive Cases
Barbara E. Stähli,Hanna Tasnady,Lukas Altwegg,Ines Bühler,Jürg Grünenfelder,Ulf Landmesser,Felix C. Tanner,Manfred Wischnewsky,Volkmar Falk,Thomas F. Lüscher,Roberto Corti,W. Maier +11 more
TL;DR: In selected patients with severe aortic stenosis TAVI is a valid therapeutic option, according to the newly revised VARC-2 standardised endpoint definitions, and the composite endpoint "early safety" was reached in 19% of patients.
Journal ArticleDOI
TCT-733 Predictors of Permanent Pacemaker Implantation in Patients Treated in Routine Clinical Practice with the Repositionable and Fully Retrievable Lotus Valve
Nicolas M. Van Mieghem,Lennart van Gils,Jochen Wöhrle,David Hildick-Smith,Sabine Bleiziffer,D J Blackman,Mohamed Abdel-Wahab,Axel Linke,Hüseyin Ince,Peter Wenaweser,Nikos Werner,Dominic J. Allocco,Keith D. Dawkins,Volkmar Falk,MaryEllen Klusacek +14 more
TL;DR: A systematic review was conducted of randomized control trials (RCTs) and observational studies comparing TAVR versus SVR in low-intermediate risk patients included in MEDLINE, EMBASE, CINAHL and Cochrane databases.